Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
$29.50
$30.65
$18.41
$45.75
$1.31B1.54482,417 shsN/A
TEK
iShares Technology Opportunities Active ETF
$28.60
-0.3%
$26.80
$19.03
$28.74
$24.02MN/A6,910 shs995 shs
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$5.64
+0.7%
$3.83
$1.87
$11.40
$489.09M-0.111.46 million shs1.33 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
0.00%0.00%0.00%0.00%0.00%
TEK
iShares Technology Opportunities Active ETF
+0.99%+1.99%+7.70%+35.33%+2,868,999,900.00%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
+6.26%+14.99%+43.59%+132.85%-41.91%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
N/AN/AN/AN/AN/AN/AN/AN/A
TEK
iShares Technology Opportunities Active ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
3.8684 of 5 stars
3.31.00.04.12.63.30.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
0.00
N/AN/AN/A
TEK
iShares Technology Opportunities Active ETF
2.87
Moderate Buy$28.60N/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
2.60
Moderate Buy$15.63177.04% Upside

Current Analyst Ratings Breakdown

Latest TERN, JPB, TEK, and MINI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2025
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$26.00 ➝ $15.00
4/21/2025
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$20.00 ➝ $20.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
$612.63M2.14$3.68 per share8.01$19.06 per share1.55
TEK
iShares Technology Opportunities Active ETF
N/AN/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/A$4.07 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
$83.73M$2.0217.6616.211.2112.08%11.52%4.51%N/A
TEK
iShares Technology Opportunities Active ETF
N/AN/A43.98N/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$88.85M-$1.09N/AN/AN/AN/A-28.81%-27.55%8/4/2025 (Estimated)

Latest TERN, JPB, TEK, and MINI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$0.29N/AN/AN/AN/AN/A
5/8/2025Q1 2025
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$0.29-$0.26+$0.03-$0.26N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
$1.214.10%N/A59.90%N/A
TEK
iShares Technology Opportunities Active ETF
N/A0.03%N/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
0.39
0.16
0.15
TEK
iShares Technology Opportunities Active ETF
N/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/A
30.89
30.89

Institutional Ownership

CompanyInstitutional Ownership
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
92.53%
TEK
iShares Technology Opportunities Active ETF
N/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
98.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
Mobile Mini, Inc. stock logo
MINI
Mobile Mini
2,04244.36 millionN/AOptionable
TEK
iShares Technology Opportunities Active ETF
N/A840,000N/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
4087.34 million86.03 millionNot Optionable

Recent News About These Companies

3 Penny Stocks Wall Street Sees With 243% Upside

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Mobile Mini stock logo

Mobile Mini NASDAQ:MINI

Mobile Mini, Inc. provides portable storage and specialty containment solutions. It operates through three segments: Storage Solutions North America, Storage Solutions United Kingdom, and Tank & Pump Solutions. The company offers various portable storage and office products, including steel storage containers and steel ground level offices serving construction companies, large and small retailers, medical centers, schools, utilities, distributors, the military, hotels, restaurants, entertainment complexes, and households for application in the storage of construction materials and equipment, retail and manufacturing inventory, documents and records, and other goods. It also provides a range of specialty containment equipment, such as steel tanks, stainless steel tank trailers, and pumps and filtration equipment, as well as roll-off, vacuum, and dewatering boxes. In addition, the company offers specialty containment services comprising transportation of containers for waste management; waste management oversight and service; system design that includes assessment of pumping, filtration, and temporary storage needs; and field services to install and connect customer containment equipment. It primarily leases its specialty products for chemical, refinery, oil and natural gas drilling, mining, and environmental service customers. As of February 1, 2018, the company operated a rental fleet of approximately 195,600 storage solution containers and office units; and 12,600 units of tank and pump solutions in the United States. Its network also consisted of 154 locations in the United States, the United Kingdom, and Canada. The company was founded in 1983 and is headquartered in Phoenix, Arizona.

iShares Technology Opportunities Active ETF NYSEARCA:TEK

$28.60 -0.09 (-0.31%)
As of 04:10 PM Eastern

The iShares Technology Opportunities Active ETF (TEK) is an exchange-traded fund that mostly invests in information technology equity. The fund is actively managed, investing in US and non-US technology companies across all market capitalizations. The fund aims for long-term growth of capital, focusing on firms with rapid growth potential in the industry TEK was launched on Oct 21, 2024 and is issued by BlackRock.

Terns Pharmaceuticals stock logo

Terns Pharmaceuticals NASDAQ:TERN

$5.64 +0.04 (+0.71%)
Closing price 04:00 PM Eastern
Extended Trading
$5.60 -0.03 (-0.62%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.